MDA-MB231B1 Triple Negative Breast Cancer (bone tropic)
Breast Cancer | Triple Negative
Between 10-20% of the human breast cancers are considered Triple Negative Breast Cancer (TNBC), which means that the tumour cells do not express the receptors for estrogen, progesterone, and Her2. In practice, that means that anticancer drugs that target these receptors or hormone therapy will not be effective. Continue reading MDA-MB231B1 Triple Negative Breast Cancer (bone tropic)